Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib

BACKGROUND: Within the class of tyrosine kinase inhibitors (TKIs), which are used for the treatment of numerous advanced cancers, lenvatinib is associated with a higher prevalence of hypertension (HT) compared with other TKIs. In this study, we investigated the effect of lenvatinib on blood pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Kei, Fujii, Hideki, Kono, Keiji, Hirabayashi, Ken, Yamatani, Satoshi, Watanabe, Kentaro, Goto, Shunsuke, Komatsu, Shohei, Fukumoto, Takumi, Nishi, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857786/
https://www.ncbi.nlm.nih.gov/pubmed/33564435
http://dx.doi.org/10.1093/ckj/sfaa137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857786/
https://www.ncbi.nlm.nih.gov/pubmed/33564435
http://dx.doi.org/10.1093/ckj/sfaa137

Ejemplares similares